Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation

被引:88
作者
Haan, S
Ferguson, P
Sommer, U
Hiremath, M
McVicar, DW
Heinrich, PC
Johnston, JA
Cacalano, NA
机构
[1] Queens Univ Belfast, Dept Immunol, Belfast BT9 7BL, Antrim, North Ireland
[2] Rhein Westfal TH Aachen, Inst Biochem, D-52074 Aachen, Germany
[3] NCI, Expt Immunol Lab, NIH, Frederick, MD 21702 USA
[4] Univ Calif Los Angeles, Ctr Hlth Sci, Dept Radiat Oncol, Los Angeles, CA 90095 USA
关键词
D O I
10.1074/jbc.M303170200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The suppressors of cytokine signaling (SOCS) are negative feedback inhibitors of cytokine and growth factor-induced signal transduction. The C-terminal SOCS box region is thought to regulate SOCS protein stability most likely via an elongin C interaction. In the present study, we have found that phosphorylation of SOCS3 at two tyrosine residues in the conserved SOCS box, Tyr(204) and Tyr(221), can inhibit the SOCS3-elongin C interaction and activate proteasome-mediated SOCS3 degradation. Jak-mediated phosphorylation of SOCS3 decreased SOCS3 protein half-life, and phosphorylation of both Tyr(204) and Tyr(221) was required to fully destabilize SOCS3. In contrast, a phosphorylation-deficient mutant of SOCS3, Y204F, Y221F, remained stable in the presence of activated Jak2 and receptor tyrosine kinases. SOCS3 stability correlated with the relative amount that bound elongin C, because in vitro phosphorylation of a SOCS3-glutathione S-transferase fusion protein abolished its ability to interact with elongin C. In addition, a SOCS3/SOCS1 chimera that co-precipitates with markedly increased elongin C, was significantly more stable than wild-type SOCS3. The data suggest that interaction with elongin C stabilizes SOCS3 protein expression and that phosphorylation of SOCS box tyrosine residues disrupts the complex and enhances proteasome-mediated degradation of SOCS3.
引用
收藏
页码:31972 / 31979
页数:8
相关论文
共 53 条
[1]   Suppressors of cytokine signalling (SOCS) in the immune system [J].
Alexander, WS .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) :410-416
[2]   Identification of SOCS-3 as a potential mediator of central leptin resistance [J].
Bjorbaek, C ;
Elmquist, JK ;
Frantz, JD ;
Shoelson, SE ;
Flier, JS .
MOLECULAR CELL, 1998, 1 (04) :619-625
[3]   Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain [J].
Cacalano, NA ;
Migone, TS ;
Bazan, F ;
Hanson, EP ;
Chen, M ;
Candotti, F ;
O'Shea, JJ ;
Johnston, JA .
EMBO JOURNAL, 1999, 18 (06) :1549-1558
[4]   Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras [J].
Cacalano, NA ;
Sanden, D ;
Johnston, JA .
NATURE CELL BIOLOGY, 2001, 3 (05) :460-465
[5]   Pim serine/threonine kinases regulate the stability of Socs-1 protein [J].
Chen, XP ;
Losman, JA ;
Cowan, S ;
Donahue, E ;
Fay, S ;
Vuong, BQ ;
Nawijn, MC ;
Capece, D ;
Cohan, VL ;
Rothman, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (04) :2175-2180
[6]  
Cohney SJ, 1999, MOL CELL BIOL, V19, P4980
[7]   Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation [J].
De Sepulveda, P ;
Ilangumaran, S ;
Rottapel, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) :14005-14008
[8]  
De Sepulveda P, 1999, EMBO J, V18, P904
[9]   Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor [J].
Dey, BR ;
Furlanetto, RW ;
Nissley, P .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 278 (01) :38-43
[10]   SOCS-3 is an insulin-induced negative regulator of insulin signaling [J].
Emanuelli, B ;
Peraldi, P ;
Filloux, C ;
Sawka-Verhelle, D ;
Hilton, D ;
Van Obberghen, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (21) :15985-15991